Over 50 revenue-generating clients benefit from the Maverix Analytic Platform in areas as diverse as pharmaceutical development, molecular diagnostics, healthcare systems, biotechnology, government laboratories and academia.

 

Empowered by Maverix, Biologist Pushes Ahead with Autism Study

We wanted a platform where everyone in the lab worked with the same tools doing exactly the same thing so results would be reliable and easy to understand. The Maverix Analytic Platform gives us exactly what we need - statistics, different graphs, different ways to understand your data - everything that makes your data apply to you.”

Marian Mellén, Postdoctoral Fellow, Rockefeller University

Stem Cell Crusader Offers Hope in Battle Against Neurological Diseases 

“With Maverix, the data are already analyzed so it doesn’t take a bioinformatics genius to interpret the data once we get it back. When we tried out Maverix, we were impressed. We decided that it was more cost-effective and probably more reliable to work with Maverix than to do it internally.”

Jeanne Loring, Professor, Scripps Research Institute

Highlighting New Biomarker Discovery Capabilities

“In our own work on ovarian cancer, we have been able to greatly accelerate our search for biomarkers by using the Maverix Analytic Platform, enabling us to progress rapidly from large, complex raw data sets to actionable insights and candidates of high interest in a matter of a few days rather than the weeks or months associated with typical collaborations.”

 Doug Taylor PhD, Professor and Vice Chair for Research, Department of Obstetrics and Gynecology at the University of Louisville School of Medicine

Maverix Complete Provides End-to-End NGS Solution

“The Maverix Complete solution allowed us to gain the advantages of using RNA-seq for expression analysis without having to invest a lot of time and money developing Next Generation Sequencing capabilities and expertise.  Maverix managed the entire library prep and NGS workflow for us, and provided us with extensive data analysis.”

 Matt Siegel, Principal Scientist, Ardelyx

Maverix works with several partners to provide an end-to-end solution from bio sample through discovery.  Interested in partnering with Maverix? Click here for more information.

Maverix Complete Provides End-to-End NGS Solution

“Maverix Biomics has built a world-class self-service NGS bioinformatics platform that takes full advantage of cloud computing. I have been impressed with their depth of knowledge and ability to automate complex RNA-seq and DNA-seq analysis.”

John Battles, Director, Bioinformatics and Study Management, Beckman Coulter Genomics 

Maverix Biomics and Elsevier Sign Cooperation Agreement

“This collaboration gives more value to our customers – not only can they use the two great tools our companies produce, but they can now save time by seamlessly using them together. This reduces their workload, reduces complexity and increases accuracy of their analysis.”

Jaqui Hodgkinson, VP Product Development, Elsevier Life Science Solutions

Maverix Strengthens Strategic Co-Marketing Alliance with QIAGEN

  “By extending our relationship with Maverix, we are providing   a seamless workflow from raw sequencing files to biological     interpretation, which will    accelerate the pace of insights         researchers gain from their RNA-seq experiments.”

Debra Toburen, Director of Product Management, QIAGEN

 

For Powerful, Interactive Exosome Analysis, SBI Turns to Maverix

“Delivering sequenced exosome data via the Maverix Analytic Platform gives our customers the ability to interactively explore and browse multiple sets of data which allows them to quickly discover new biomarkers that they hadn’t been aware of before.”

Travis Antes, Director of Product Development, System Biosciences, Inc. 

A Complete Solution for Your NGS Workflow

WaferGen Biosystems and Maverix Biomics have joined together to provide a fast, simple and complete end-to-end solution for your NGS workflow.

99 Lives Cat Genome Sequencing Initiative Empowers Discovery by Building Community on the Maverix Analytic Platform

LYONS_Leslie

“We are thrilled that the whole genomic sequencing of cats has led to such impactful discoveries which we believe can provide an efficient and effective model for research into eye diseases affecting humans. Using whole genome sequencing enabled us to find this mutation, which would not have been possible using traditional microarray technology.”

Leslie Lyons, Gilbreath-McLorn Professor for Comparative Medicine, University of Missiouri Columbia

Tomatoes, our first Community of Discovery

“I’m very excited to work with Maverix to help create a new tomato community-focused analytic portal as the first example of a ‘Community of Discovery. Having a destination site where anyone in the Solanum community can analyze, visualize, and openly share new sequencing data should enable new opportunities for collaboration in the field.”

Barbara Baker PhD, Molecular Geneticist at the US Department of Agriculture Agricultural Research Service Plant Gene Expression Center in Albany CA, and Adjunct Professor of Plant & Microbial Biology at the University of California